Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sidhant Jain, Neha Vimal, Nilza Angmo, Madhumita Sengupta & Suraj Thangaraj. (2023) Dengue Vaccination: Towards a New Dawn of Curbing Dengue Infection. Immunological Investigations 52:8, pages 1096-1149.
Read now
Read now
Lin Cui, Huoqing Huang, Honglian Zhang, Xiaolu Wang, Xing Qin, Tao Tu, Jie Zhang, Xiaoyun Su, Huimin Yu, Yingguo Bai, Huiying Luo, Bin Yao & Yuan Wang. (2022) Recombinant expression of hen egg white lysozyme with the assistance of xylanase fusion partner in Pichia pastoris. Bioengineered 13:5, pages 13860-13871.
Read now
Read now
Mark Verdecia, John F. Kokai-Kun, Maura Kibbey, Sarita Acharya, Jaap Venema & Fouad Atouf. (2021) COVID-19 vaccine platforms: Delivering on a promise?. Human Vaccines & Immunotherapeutics 17:9, pages 2873-2893.
Read now
Read now
Rahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, Upasana Arora, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Sathyamangalam Swaminathan & Navin Khanna. (2019) Next generation designer virus-like particle vaccines for dengue. Expert Review of Vaccines 18:2, pages 105-117.
Read now
Read now
Articles from other publishers (61)
Nomfundo Ntombela, Matome Matsiela, Sbahle Zuma, Suhavna Hiralal, Leeann Naicker, Nobalanda Mokoena & Thandeka Khoza. (2023) Production of recombinant lumpy skin disease virus A27L and L1R proteins for application in diagnostics and vaccine development. Vaccine: X 15, pages 100384.
Crossref
Crossref
Ryo Okuyama. (2023) mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions. Vaccines 11:12, pages 1737.
Crossref
Crossref
Anirudha Chattopadhyay, A. Abdul Kader Jailani & Bikash Mandal. (2023) Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness. Vaccines 11:8, pages 1347.
Crossref
Crossref
Wei Liu, Peizhao Jiang, Tao Song, Keli Yang, Fangyan Yuan, Ting Gao, Zewen Liu, Chang Li, Rui Guo, Shaobo Xiao, Yongxiang Tian & Danna Zhou. (2023) A Recombinant Chimera Vaccine Composed of LTB and Mycoplasma hyopneumoniae Antigens P97R1, mhp390 and P46 Elicits Cellular Immunologic Response in Mice. Vaccines 11:8, pages 1291.
Crossref
Crossref
Eleonora Martinis, Carolina Ricci, Caterina Trevisan, Gaia Tomadini & Silvia Tonon. (2023) Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer. Pharmaceutics 15:7, pages 1969.
Crossref
Crossref
Rabeya Tajnur, Refaya Rezwan, Md. Abdul Aziz & Mohammad Safiqul Islam. (2023) An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review. Health Science Reports 6:7.
Crossref
Crossref
Mingzhu Shao, Ning Cui, Yangyang Tang, Fanruo Chen, Yingying Cui, Guanghui Dang & Siguo Liu. (2023) A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice. npj Vaccines 8:1.
Crossref
Crossref
Halie M. Rando, Ronan Lordan, Alexandra J. Lee, Amruta Naik, Nils Wellhausen, Elizabeth Sell, Likhitha Kolla, Anthony Gitter, Casey S. Greene, Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Jesse G. Meyer, Ariel I. Mundo, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang & Nils Wellhausen. (2023) Application of Traditional Vaccine Development Strategies to SARS-CoV-2. mSystems 8:2.
Crossref
Crossref
Tatiana Ianshina, Anton Sidorin, Kristina Petrova, Maria Shubert, Anastasiya Makeeva, Elena Sambuk, Anastasiya Govdi, Andrey Rumyantsev & Marina Padkina. (2023) Effect of Methionine on Gene Expression in Komagataella phaffii Cells. Microorganisms 11:4, pages 877.
Crossref
Crossref
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, Shokouh Rezaei, Vuk Uskoković, Mahdi Alijanianzadeh, Vladimir N. Uversky, Seyed Omid Ranaei Siadat, Sina Mozaffari-Jovin & Yahya Sefidbakht. (2023) An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. Progress in Biophysics and Molecular Biology 178, pages 32-49.
Crossref
Crossref
Justin C. Konje, Mariam Al Beloushi & Badreldeen Ahmed. (2023) Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy. Viruses 15:3, pages 621.
Crossref
Crossref
Samira Hossaini Alhashemi, Fatemeh Ahmadi & Ali Dehshahri. (2023) Lessons learned from COVID-19 pandemic: Vaccine platform is a key player. Process Biochemistry 124, pages 269-279.
Crossref
Crossref
Sepideh Hozori, Rezvan Rahimi & Zahra Shekofteh. (2023) An immunoinformatics approach to design a potential multi-epitope subunit vaccine against Bordetella pertussis. Informatics in Medicine Unlocked 42, pages 101358.
Crossref
Crossref
Shilpa Mohanty, Babbal & Yogender Pal Khasa. 2023. Fungi and Fungal Products in Human Welfare and Biotechnology. Fungi and Fungal Products in Human Welfare and Biotechnology
513
569
.
Benjamin Offei, Stephanie Braun-Galleani, Anjan Venkatesh, William T. Casey, Kevin E. O’Connor, Kevin P. Byrne & Kenneth H. Wolfe. (2022) Identification of genetic variants of the industrial yeast Komagataella phaffii (Pichia pastoris) that contribute to increased yields of secreted heterologous proteins. PLOS Biology 20:12, pages e3001877.
Crossref
Crossref
Vipul Kumar, Sahil Kumar & Prabodh Chander Sharma. (2022) Recent advances in the vaccine development for the prophylaxis of SARS Covid-19. International Immunopharmacology 111, pages 109175.
Crossref
Crossref
Amir Ghaemi, Parisa Roshani Asl, Hedieh Zargaran, Delaram Ahmadi, Asim Ali Hashimi, Elahe Abdolalipour, Sahar Bathaeian & Seyed Mohammad Miri. (2022) Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity. Frontiers in Immunology 13.
Crossref
Crossref
Zhi Cao, Ke Zhang, Heng Zhang, Hongliang Zhang, Ying Yu, Dehua Yin, Hu Shan & Zhihua Qin. (2022) Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits. Frontiers in Microbiology 13.
Crossref
Crossref
Rosendo Luria-Pérez, Luis A. Sánchez-Vargas, Paola Muñoz-López & Gabriela Mellado-Sánchez. (2022) Mucosal Vaccination: A Promising Alternative Against Flaviviruses. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Monika Stahl, Jonas Holzinger, Sigrid Bülow & Achim M. Goepferich. (2022) Enzyme-triggered antigen release enhances cross-presentation by dendritic cells. Nanomedicine: Nanotechnology, Biology and Medicine 42, pages 102545.
Crossref
Crossref
Khue G. Nguyen, Siena M. Mantooth, Maura R. Vrabel & David A. Zaharoff. (2022) Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2. Frontiers in Immunology 13.
Crossref
Crossref
Wei Li, Junli Meng, Xinghuan Ma, Jiaqi Lin & Xueguang Lu. (2022) Advanced materials for the delivery of vaccines for infectious diseases. Biosafety and Health 4:2, pages 95-104.
Crossref
Crossref
Albert To, Chih-Yun Lai, Teri Ann S. Wong, Madhuri Namekar, Michael M. Lieberman & Axel T. Lehrer. (2022) Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Zrinka Matić & Maja Šantak. (2021) Current view on novel vaccine technologies to combat human infectious diseases. Applied Microbiology and Biotechnology 106:1, pages 25-56.
Crossref
Crossref
Anjali Pandya, Sreeranjini Pulakkat, Sarika Jadhav & Vandana Patravale. 2022. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics
269
293
.
Wan Sun, Yimeng Zuo, Zhanyi Yao, Jucan Gao, Zengyi Shao & Jiazhang Lian. 2022. Synthetic Biology of Yeasts. Synthetic Biology of Yeasts
251
292
.
Jyoti Gupta, Amit Kumar & Milan Surjit. 2022. Vaccine Design. Vaccine Design
117
141
.
Jing Zhang, Na Jin, Ning Ji, Xinyi Chen, Yu Shen, Ting Pan, Lin Li, Sheng Li, Weina Zhang & Fengwei Huo. (2021) The Encounter of Biomolecules in Metal–Organic Framework Micro/Nano Reactors. ACS Applied Materials & Interfaces 13:44, pages 52215-52233.
Crossref
Crossref
Trung Hieu Pham, Shreesha Rao, Ta-Chih Cheng, Pei-Chi Wang & Shih-Chu Chen. (2021) The moonlighting protein fructose 1,6-bisphosphate aldolase as a potential vaccine candidate against Photobacterium damselae subsp. piscicida in Asian sea bass (Lates calcarifer). Developmental & Comparative Immunology 124, pages 104187.
Crossref
Crossref
Sushobhan K Bandyopadhyay, Stephen A Morris, Darren N Nesbeth & Daniel G Bracewell. (2021) Lipid reduction to improve clarification and filterability during primary recovery of intracellular products in yeast lysates using exogenous lipase. Journal of Chemical Technology & Biotechnology 96:11, pages 3166-3174.
Crossref
Crossref
John H. Eldridge, Michael A. Egan, Demetrius Matassov, Stefan Hamm, Luz Hermida, Tracy Chen, Marc Tremblay, Susan Sciotto-Brown, Rong Xu, Antony Dimitrov, Emily R. Smith, Marc Gurwith & Robert T. Chen. (2021) A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses. Vaccine 39:38, pages 5436-5441.
Crossref
Crossref
Sonakshi De, Diethard Mattanovich, Pau Ferrer & Brigitte Gasser. (2021)
Established tools and emerging trends for the production of recombinant proteins and metabolites in
Pichia pastoris
. Essays in Biochemistry 65:2, pages 293-307.
Crossref
Crossref
Lu Lu, Weixi Xiong, Jie Mu, Qi Zhang, Hesheng Zhang, Ling Zou, Weimin Li, Li He, Josemir W. Sander & Dong Zhou. (2021) The potential neurological effect of the COVID‐19 vaccines: A review. Acta Neurologica Scandinavica 144:1, pages 3-12.
Crossref
Crossref
Natnaree Inthong, Sarawan Kaewmongkol, Nattakan Meekhanon, Eukote Suwan, Wanat Sricharern, Khomson Satchasataporn, Rungthiwa SinsiriKaitkanoke Sirinarumitr & Theerapol Sirinarumitr. (2021) Expression of recombinant 35 kDa fragment of VP2 protein of canine parvovirus using Escherichia coli expression system. Veterinary World, pages 1682-1688.
Crossref
Crossref
Wei Zhan, Manish Muhuri, Phillip W. L. Tai & Guangping Gao. (2021) Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?. Frontiers in Immunology 12.
Crossref
Crossref
Jonaid Ahmad Malik, Almas Hanif Mulla, Tahmeena Farooqi, Faheem Hyder Pottoo, Sirajudheen Anwar & Kannan R.R. Rengasamy. (2021) Targets and strategies for vaccine development against SARS-CoV-2. Biomedicine & Pharmacotherapy 137, pages 111254.
Crossref
Crossref
Trung Hieu Pham, Ta-Chih Cheng, Pei-Chi Wang & Shih-Chu Chen. (2021) Protective efficacy of four heat-shock proteins as recombinant vaccines against photobacteriosis in Asian seabass (Lates calcarifer). Fish & Shellfish Immunology 111, pages 179-188.
Crossref
Crossref
Anu Sharma, RaviPrakash Sharma, Rimplejeet Kaur, Ria Sharma & Surjit Singh. (2021) A comprehensive insight on the COVID-19 vaccine candidates. Journal of Family Medicine and Primary Care 10:7, pages 2457.
Crossref
Crossref
Ravichandran Vijaya Abinaya & Pragasam Viswanathan. 2021. Translational Biotechnology. Translational Biotechnology
27
52
.
Jagannath Mondal, Vishnu Revuri, Mohammad Nazmul Hasan & Yong-kyu Lee. 2021. Bioinspired and Biomimetic Materials for Drug Delivery. Bioinspired and Biomimetic Materials for Drug Delivery
139
170
.
Emin Umit Bagriacik. 2021. Nanotechnology Applications in Health and Environmental Sciences. Nanotechnology Applications in Health and Environmental Sciences
291
298
.
Kranti Kuruti, Viswanath Vittaladevaram, Sudheer Venkatesh Urity, P. Palaniappan & Ravi Uday Bhaskar. (2020) Evolution of Pichia pastoris as a model organism for vaccines production in healthcare industry. Gene Reports 21, pages 100937.
Crossref
Crossref
Albert I. Ugochukwu, Peter W. B. Phillips & Brian J. Ochieng’. (2020) Driving Adoption and Commercialization of Subunit Vaccines for Bovine Tuberculosis and Johne’s Disease: Policy Choices and Implications for Food Security. Vaccines 8:4, pages 667.
Crossref
Crossref
Mina Shahnazari, Pouria Samadi, Mona Pourjafar & Akram Jalali. (2020) Therapeutic vaccines for colorectal cancer: The progress and future prospect. International Immunopharmacology 88, pages 106944.
Crossref
Crossref
J S Tregoning, E S Brown, H M Cheeseman, K E Flight, S L Higham, N-M Lemm, B F Pierce, D C Stirling, Z Wang & K M Pollock. (2020) Vaccines for COVID-19. Clinical and Experimental Immunology 202:2, pages 162-192.
Crossref
Crossref
Mohsen Karbalaei, Seyed A. Rezaee & Hadi Farsiani. (2020)
Pichia pastoris
: A highly successful expression system for optimal synthesis of heterologous proteins
. Journal of Cellular Physiology 235:9, pages 5867-5881.
Crossref
Crossref
Zainab Saeed, Orene Greer & Nishel Mohan Shah. (2020) Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?. Antibodies 9:3, pages 38.
Crossref
Crossref
Sonali Kochhar, Denny Kim, Jean-Louis Excler, Richard C. Condit, James S. Robertson, Stephen Drew, Mike Whelan, David Wood, Patricia E. Fast, Marc Gurwith, Bettina Klug, Najwa Khuri-Bulos, Emily R. Smith & Robert T Chen. (2020) The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Vaccine 38:35, pages 5734-5739.
Crossref
Crossref
Mariana Fonseca Xisto, John Willians Oliveira Prates, Ingrid Marques Dias, Roberto Sousa Dias, Cynthia Canedo da Silva & Sérgio Oliveira de Paula. (2020) NS1 Recombinant Proteins Are Efficiently Produced in Pichia pastoris and Have Great Potential for Use in Diagnostic Kits for Dengue Virus Infections. Diagnostics 10:6, pages 379.
Crossref
Crossref
Lu Tan, Tao Zheng, Man Li, Xiaofang Zhong, Yao Tang, Ming Qin & Xun Sun. (2020) Optimization of an mRNA vaccine assisted with cyclodextrin-polyethyleneimine conjugates. Drug Delivery and Translational Research 10:3, pages 678-689.
Crossref
Crossref
Daniela Calina, Anca Docea, Demetrios Petrakis, Alex Egorov, Aydar Ishmukhametov, Alexsandr Gabibov, Michael Shtilman, Ronald Kostoff, Félix Carvalho, Marco Vinceti, Demetrios Spandidos & Aristidis Tsatsakis. (2020) Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review). International Journal of Molecular Medicine 46:1, pages 3-16.
Crossref
Crossref
Alex J. Spice, Rochelle Aw, Daniel G. Bracewell & Karen M. Polizzi. (2020) Synthesis and Assembly of Hepatitis B Virus-Like Particles in a Pichia pastoris Cell-Free System. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Sugunakar Vuree, Gopal Kumar Prajapati & Simranjeet Singh. 2020. New and Future Developments in Microbial Biotechnology and Bioengineering. New and Future Developments in Microbial Biotechnology and Bioengineering
219
229
.
Luyen Thi Phung, Sujittra Chaiyadet, Nuttanan Hongsrichan, Javier Sotillo, Hang Dinh Thi Dieu, Canh Quang Tran, Paul J Brindley, Alex Loukas & Thewarach Laha. (2019) Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis. Parasitology Research 118:12, pages 3419-3427.
Crossref
Crossref
Zhen XvJinhui LvJie JiangWenhuan WangFangfang FengLifang ZhangXiangyang XueWenshu Li. (2019)
Effective Neutralizing Antibody Produced in Mice Directly Immunized with Integrated
Pichia pastoris
Expressing HPV16L1 Protein
. Viral Immunology 32:7, pages 308-317.
Crossref
Crossref
Mandy Gebauer, Hans C. Hürlimann, Martina Behrens, Thorsten Wolff & Sven-Erik Behrens. (2019) Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme. Vaccine 37:37, pages 5578-5587.
Crossref
Crossref
Faezeh Borzooee & Mani Larijani. (2019) Pichia pastoris as a host for production and isolation of mutagenic AID/APOBEC enzymes involved in cancer and immunity. New Biotechnology 51, pages 67-79.
Crossref
Crossref
Shih-Chi Wang, Hsin-Yu Liao, Jia-Yan Zhang, Ting-Jen Rachel Cheng & Chi-Huey Wong. (2019) Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris. Virology 526, pages 125-137.
Crossref
Crossref
Baoquan Han, Kun Xu, Zhongtian Liu, Wei Ge, Simin Shao, Pengcheng Li, Nana Yan, Xinyi Li & Zhiying Zhang. (2019) Oral yeast-based DNA vaccine confers effective protection from Aeromonas hydrophila infection on Carassius auratus. Fish & Shellfish Immunology 84, pages 948-954.
Crossref
Crossref
Hongbo Li & Yuxian Xia. (2018) Recombinant production of the insecticidal scorpion toxin BjαIT in Escherichia coli. Protein Expression and Purification 142, pages 62-67.
Crossref
Crossref
Cesar Andres Diaz Arias, Daniela de Araujo Viana Marques, Luciana Pellegrini Malpiedi, Andrea Queiroz Maranh?o, Dulcineia Abdalla Saes Parra, Attilio Converti & Adalberto Pessoa Junior. (2017) Cultivation of Pichia pastoris carrying the scFv anti LDL (?) antibody fragment. Effect of preculture carbon source. Brazilian Journal of Microbiology 48:3, pages 419-426.
Crossref
Crossref